ArticleCancer science2019

Efficacy of the NCCV Cocktail-1 vaccine for refractory pediatric solid tumors: A phase I clinical trial.

Yu Akazawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.